We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-5.07%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.24B
AUM Growth
-$48.8M
(-1.5%)
Cap. Flow
-$14.9M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
101
New
30
Increased
21
Reduced
24
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$134M |
| 2 |
HCA Healthcare
HCA
|
+$114M |
| 3 |
Apple
AAPL
|
+$108M |
| 4 |
Elevance Health
ELV
|
+$69.3M |
| 5 |
Gilead Sciences
GILD
|
+$69.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AerCap
AER
|
+$126M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$122M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$91.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$85.3M |
| 5 |
Textron
TXT
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.12% |
| 2 | Technology | 13.88% |
| 3 | Financials | 7.38% |
| 4 | Communication Services | 6.63% |
| 5 | Consumer Discretionary | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
AerCap
AER
$23.4B
| – | – |
-2,922,514
| Closed | -$126M |
|
|
BLUE
77
DELISTED
bluebird bio
BLUE
| – | – |
-51,557
| Closed | -$42.9M |
|
78
Coherus Oncology
CHRS
$217M
| – | – |
-172,638
| Closed | -$3.96M |
|
79
Fortune Brands Innovations
FBIN
$5.86B
| – | – |
-1,050,356
| Closed | -$49.8M |
|
80
Home Depot
HD
$337B
| – | – |
-276,778
| Closed | -$36.6M |
|
81
McKesson
MCK
$104B
| – | – |
-72,627
| Closed | -$14.3M |
|
82
Molina Healthcare
MOH
$10.4B
| – | – |
-587,956
| Closed | -$35.4M |
|
83
MaxLinear
MXL
$5.19B
| – | – |
-81,443
| Closed | -$1.2M |
|
84
ServiceNow
NOW
$120B
| – | – |
-2,409,635
| Closed | -$41.7M |
|
85
Regenxbio
RGNX
$616M
| – | – |
-119,092
| Closed | -$1.98M |
|
|
SCHW
86
Charles Schwab
SCHW
$182B
| – | – |
-2,779,577
| Closed | -$91.5M |
|
87
Atlassian
TEAM
$26.5B
| – | – |
-98,357
| Closed | -$2.96M |
|
|
88
Teva Pharmaceuticals
TEVA
$40.4B
| – | – |
-1,860,952
| Closed | -$122M |
|
|
89
Textron
TXT
$14.9B
| – | – |
-1,573,009
| Closed | -$66.1M |
|
90
UnitedHealth
UNH
$382B
| – | – |
-174,697
| Closed | -$20.6M |
|
91
United Rentals
URI
$65.7B
| – | – |
-396,663
| Closed | -$28.8M |
|
|
MIC
92
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| – | – |
-563,552
| Closed | -$40.9M |
|
|
AMAG
93
DELISTED
AMAG Pharmaceuticals
AMAG
| – | – |
-282,420
| Closed | -$8.53M |
|
|
JUNO
94
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – |
-150,684
| Closed | -$6.63M |
|
|
CELG
95
DELISTED
Celgene Corp
CELG
| – | – |
-159,895
| Closed | -$19.1M |
|
Similar funds
DAM
MAM
LCM
PRS
DAM
KCM
CF
MIA
PFM Health Sciences's Q1 2016 Portfolio in Review
As of Q1 2016, PFM Health Sciences held 101 positions worth $3.24B, down 1.5% from $3.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
PFM Health Sciences's Q1 2016 filing shows 30 new, 21 increased, 24 reduced and 20 closed positions. Its largest new stake was AbbVie: 2,396,328 shares worth $137M. The largest sale was AerCap, an estimated $126M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.
- PFM Health Sciences's largest Q1 2016 buy was AbbVie: 2,396,328 shares worth $137M.
- PFM Health Sciences added most to HCA Healthcare in Q1 2016, an estimated $114M increase.
- PFM Health Sciences's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $85.3M.
- PFM Health Sciences fully exited AerCap in Q1 2016, selling an estimated $126M.
- PFM Health Sciences's ten largest holdings make up 35% of its $3.24B portfolio in Q1 2016.
- PFM Health Sciences opened 30 new positions and closed 20 in Q1 2016.
- PFM Health Sciences's portfolio value fell 1.5% quarter-over-quarter to $3.24B.
Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.